Incidence of fractures in young women with breast cancer - a retrospective cohort study.
Ontology highlight
ABSTRACT: In recent years, cancer treatment-induced bone loss (CTIBL) and increased risk of fracture has become an emerging problem as breast cancer (BC) survival has increased due to early diagnosis and improved treatments. In premenopausal women with BC, chemotherapy and tamoxifen are the treatments of choice in hormone receptor-negative and hormone receptor-positive BC respectively. Their effect on fracture risk has only been investigated in a few small-scale studies. Therefore, we investigated the fracture risk in a cohort study based on data from the Disease Analyzer database (IQVIA) and included 1761 individuals with BC and 1761 healthy women for comparison. After applying similar inclusion criteria, patients with BC were matched 1:1 to those without BC with regard to age, index year, and phys
SUBMITTER: Stumpf U
PROVIDER: S-EPMC6698802 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA